HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ethyl 2- amino- 6- bromo- 4- (1- cyano- 2- ethoxy- 2- oxoethyl)- 4H- chromene- 3- carboxylate

synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia
Also Known As:
HA 14-1; HA14-1
Networked: 46 relevant articles (4 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Skommer, Joanna: 4 articles (06/2011 - 03/2006)
2. Tian, Defeng: 4 articles (10/2009 - 12/2006)
3. Xing, Chengguo: 4 articles (10/2009 - 12/2006)
4. Doshi, Jignesh M: 4 articles (10/2009 - 12/2006)
5. Reiners, John J: 4 articles (05/2007 - 09/2002)
6. Kim, Gi-Young: 3 articles (06/2010 - 03/2009)
7. Choi, Yung Hyun: 3 articles (06/2010 - 03/2009)
8. Pelkonen, Jukka: 3 articles (12/2007 - 03/2006)
9. Wlodkowic, Donald: 3 articles (12/2007 - 03/2006)
10. Kessel, David: 3 articles (05/2007 - 09/2002)

Related Diseases

1. Neuroblastoma
2. Lymphoma (Lymphomas)
3. Necrosis
4. Neoplasms (Cancer)
5. Leukemia

Related Drugs and Biologics

1. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
2. Apigenin
3. Genistein
4. Staurosporine
5. Thapsigargin
6. Tunicamycin
7. 3-O-methylsphingomyelin
8. Proteins (Proteins, Gene)
9. JNK Mitogen-Activated Protein Kinases
10. Reactive Oxygen Species (Oxygen Radicals)

Related Therapies and Procedures

1. Photochemotherapy (Photodynamic Therapy)
2. Radiotherapy
3. Drug Therapy (Chemotherapy)